证券代码：301317 证券简称：鑫磊股份 公告编号：2025-036 鑫磊压缩机股份有限公司 第三届董事会第二十次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 鑫磊压缩机股份有限公司（以下简称"公司"）第三届董事会第二十次会议 于 2025 年 7 月 15 日在公司办公楼会议室以现场结合通讯表决的方式召开。会议 通知于 2025 年 7 月 10 日以微信、电话、电子邮件等方式向全体董事送达会议通 知。会议应出席董事 7 人，实际出席董事 7 人，其中，董事钟佳妤女士，独立董 事曹亮亮女士以通讯表决方式出席会议。 会议由董事长钟仁志先生召集和主持，蔡海红女士、陈巧雯女士、江丹女士、 蔡健龙先生列席。会议的召集、召开和表决程序符合《中华人民共和国公司法》 《中华人民共和国证券法》等相关法律、部门规章、规范性文件和《鑫磊压缩机 股份有限公司章程》（以下简称《公司章程》）的规定。 二、董事会会议审议情况 经出席会议的全体董事认真审议，通过了以下议案： 1、审议通过了《关于调整2024年限制性股票激励计划授予价格的议案》 鉴 ...

（二）最近 12 个月内被中国证监会及其派出机构认定为不适当人选； （三）最近 12 个月内因重大违法违规行为被中国证监会及其派出机构行政 处罚或者采取市场禁入措施； （四）具有《公司法》规定的不得担任公司董事、高级管理人员情形的； （五）法律法规规定不得参与上市公司股权激励的； 鑫磊压缩机股份有限公司董事会薪酬与考核委员会 关于公司2024年限制性股票激励计划预留授予激励对象名 单（截至授予日）的核查意见 鑫磊压缩机股份有限公司（以下简称"公司"）第三届董事会薪酬与考核委 员会依据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民 共和国证券法》《上市公司股权激励管理办法》（以下简称"《管理办法》"）、 《深圳证券交易所创业板股票上市规则》（以下简称"《上市规则》"）、《深 圳证券交易所创业板上市公司自律监管指南第 1 号——业务办理》和《鑫磊压缩 机股份有限公司章程》（以下简称"《公司章程》"）等有关规定，对公司 2024 年限制性股票激励计划（以下简称"本次激励计划"）预留授予激励对象名单（截 至授予日）进行了核查，发表核查意见如下： 一、本次激励计划预留授予的激励对象与公司 2024 年第 ...

鑫磊股份：拟境外发行股份（H股）并在港交所上市 智通财经7月15日电，鑫磊股份(301317.SZ)公告称，公司于2025年7月15日召开第三届董事会第二十次 会议，审议通过了《关于授权公司管理层启动公司境外发行股份（H股）并在香港联合交易所有限公司 上市相关筹备工作的议案》。公司计划与相关中介机构就本次H股上市的具体推进工作进行商讨，关于 本次H股上市的细节尚未确定。本次H股上市需提交公司董事会和股东大会审议，并需取得相关政府机 构、监管机构备案、批准或核准。 ...

Industry Rating - The report maintains an "Outperform" rating for the scientific instruments industry, consistent with the previous rating [1]. Core Insights - The scientific instruments market in China surpassed 220 billion yuan in 2023, with a growth rate exceeding 12%. The market is dominated by high-end foreign brands, and there is a significant push for domestic alternatives driven by government policies [2][12]. - The domestic market for mass spectrometers reached 16.712 billion yuan in 2023, with foreign companies holding over 90% of the global market share. The import rate for mass spectrometers has decreased from 89% in 2018 to 81% in 2023, indicating a gradual shift towards domestic production [3][41]. - The electronic measurement instruments market is projected to exceed 40 billion yuan in 2024, with a notable focus on mid-to-high-end products. The market for oscilloscopes is expected to reach 650 million USD by 2025 [4]. Summary by Sections 1. Scientific Instruments Industry - The scientific instruments industry is characterized by high-end foreign brands dominating the market, while domestic brands struggle to gain market share. The government has introduced various policies to promote domestic innovation and application of scientific instruments [2][24]. 2. Scientific Analysis Instruments - The market for scientific analysis instruments is vast, with mass spectrometers and chromatographs showing low domestic production rates. The mass spectrometer market is expected to grow significantly, with a focus on high-resolution and triple quadrupole models as key areas for domestic manufacturers to target [25][50]. 3. Electronic Measurement Instruments - The electronic measurement instruments market is rapidly expanding, with a projected market size of 16.307 billion USD globally by 2024. The domestic market is expected to exceed 40 billion yuan, with a significant portion of high-end products still being imported [4][6]. 4. Policy Guidance - Recent government policies have aimed to support the development of domestic scientific instruments, including tax exemptions for imported instruments used in research and education, which will lower costs for research institutions [21][24].

Core Viewpoint - The newly revised "Management Measures for Information Disclosure of Listed Companies" has been officially implemented on July 1, 2023, incorporating recent regulatory practices and enhancing supervision of key matters [1][4]. Summary by Sections Implementation of New Regulations - The revised information disclosure measures were publicly solicited for opinions in December 2024 and officially released on March 28, 2023 [1]. - Key changes include strengthened risk disclosure requirements, increased regulation on outsourcing of information disclosure, and an adjustment of the maximum penalty to 100,000 yuan [1]. Companies Facing Penalties - On the first day of the new regulations, *ST Wan Fang and Ren Ren Le were publicly reprimanded for information disclosure issues [4][5]. - *ST Wan Fang initially forecasted a net profit of 20 million to 25 million yuan for 2024 but later revised it to a loss, leading to a public reprimand for failing to disclose accurate performance forecasts [4]. - Ren Ren Le also faced similar issues, with a significant discrepancy between its profit forecast and the audited results, resulting in a public reprimand [5]. Regulatory Actions and Statistics - In June, 18 companies were subjected to regulatory measures related to information disclosure, including failures in timely and accurate reporting [8]. - Specific companies like Jun Yao Health and Long Yang Technology were noted for not meeting disclosure standards in their performance forecasts [8]. - Two companies, Mei Chen Technology and Song Cheng Performing Arts, were penalized for accounting errors that led to inaccurate disclosures [9][11]. Additional Company Cases - ST Jing Gu received a regulatory letter regarding asset freezing and the need for risk disclosure, aligning with the new regulations' emphasis on risk factors [6][7]. - Companies like Heng Bang and Jing Yi failed to disclose critical information, receiving regulatory letters for their omissions [12]. Conclusion - The new information disclosure regulations aim to enhance transparency and accountability among listed companies, with immediate repercussions observed in the market [1][4][8].

Core Viewpoint - The Shenzhen Stock Exchange issued a regulatory letter to Xilei Compressor Co., Ltd. and its executives for failing to comply with disclosure obligations regarding the use of idle raised funds [1][2][6] Group 1: Company Actions - Xilei Compressor's board approved the use of up to RMB 200 million of idle raised funds for cash management on May 7, 2024, but failed to disclose this in a timely manner, only holding a supplementary meeting on May 28, 2025 [1][5] - The total amount raised by Xilei Compressor was RMB 812.33 million, with a net amount of RMB 698.31 million, exceeding the original plan by RMB 24.51 million [3][4] Group 2: Regulatory Violations - The company violated multiple articles of the revised 2025 Growth Enterprise Market Stock Listing Rules and the Self-Regulatory Guidelines for Listed Companies [2][6] - Key executives, including the chairman and general manager, failed to fulfill their duties, leading to further violations of the same regulations [2][6] Group 3: Recommendations and Reminders - The Shenzhen Stock Exchange urged the company and its executives to take the issues seriously, learn from the mistakes, and ensure timely rectification to prevent recurrence [7][8]

证券代码：301317 证券简称：鑫磊股份 公告编号：2025-032 鑫磊压缩机股份有限公司 关于公司及相关人员收到浙江证监局警示函的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 鑫磊压缩机股份有限公司（以下简称"公司"）于近日收到中国证券监督管 理委员会浙江监管局（以下简称"浙江证监局"）出具的《关于对鑫磊压缩机股 份有限公司、钟仁志、钟佳妤、金丹君采取出具警示函措施的决定》（〔2025〕 129号）（以下简称"警示函"）。现将相关情况公告如下： 一、警示函的主要内容 鑫磊压缩机股份有限公司、钟仁志、钟佳妤、金丹君： 鑫磊压缩机股份有限公司于2024年5月7日召开董事会审议通过《关于使用部 分闲置募集资金进行现金管理的议案》，同意公司使用最高额不超过人民币 20,000万元（含本数）的部分闲置募集资金进行现金管理，该额度自公司董事会 审议通过之日起12个月内有效。前述投资期限到期后，公司继续使用部分闲置募 集资金进行现金管理。公司未就上述事项及时履行审议程序和信息披露义务，直 至2025年5月28日才召开董事会会议补充审议并披露。 根据《上市公司信 ...

Core Viewpoint - The company has completed the "Annual Production of 800,000 Small Air Compressors Technical Reform Project" and is planning to conclude this fundraising project, having reached the predetermined usable state [1][5]. Fundraising Overview - The company issued 39.3 million shares at a price of 20.67 RMB per share, raising a total of 812.33 million RMB, with a net amount of 698.31 million RMB after deducting underwriting fees and other related expenses [1][2]. - The funds raised are stored in a dedicated account, and a tripartite supervision agreement has been signed with the sponsor and the bank [2]. Investment Project Details - The total investment for the "Annual Production of 30,000 Screw Air Compressors Technical Reform Project" is 453.17 million RMB, with the entire amount sourced from the raised funds [2]. - The company has also approved the use of excess funds for additional projects, amounting to 172.14 million RMB [3]. Project Completion and Fund Usage - The "Annual Production of 800,000 Small Air Compressors Technical Reform Project" has achieved its intended use status, with a total of 105.53 million RMB allocated, of which 43.72 million RMB has been spent [5][6]. - The remaining funds are planned to be managed in accordance with regulatory guidelines, with a focus on prudent and reasonable allocation based on operational needs [7].

证券代码：301317 证券简称：鑫磊股份 公告编号：2025-031 鑫磊压缩机股份有限公司 关于部分募投项目结项的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 鑫磊压缩机股份有限公司（以下简称"公司"）首次公开发行股票募集资金 投资项目"年产80万台小型空压机技改项目"已达到预定可使用状态，公司拟对 该募投项目进行结项。根据《上市公司募集资金监管规则》《深圳证券交易所上 市公司自律监管指引第 2 号——创业板上市公司规范运作》等有关规定，该事 项无需提交公司董事会、股东会审议。现将具体情况公告如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意鑫磊压缩机股份有限公司首次公开发 行股票注册的批复》（证监许可〔2022〕2325 号）同意注册，并经深圳证券交易 所同意，公司公开发行人民币普通股（A 股）3,930.00 万股，每股面值 1.00 元， 发行价格 20.67 元/股，募集资金总额人民币 812,331,000.00 元，扣除保荐承销费用 （不含税）人民币 79,529,935.57 元，减除其他与本次发行权益性证券直接相关的 ...

中泰证券股份有限公司 关于鑫磊压缩机股份有限公司 补充确认并继续使用部分闲置募集资金进行现金管理的核查意 见 中泰证券股份有限公司（以下简称"中泰证券"或"保荐机构"）作为鑫磊 压缩机股份有限公司（以下简称"公司"或"鑫磊股份"）首次公开发行股票并 在创业板上市的保荐机构，根据《深圳证券交易所创业板股票上市规则》《深圳 证券交易所上市公司自律监管指引第2号——创业板上市公司规范运作》《上市 公司监管指引第2号——上市公司募集资金管理和使用的监管要求》等文件的要 求，对鑫磊股份补充确认并继续使用部分闲置募集资金进行现金管理的事项进行 了核查，具体核查情况如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意鑫磊压缩机股份有限公司首次公开发 行股票注册的批复》（证监许可〔2022〕2325号）同意注册，并经深圳证券交易 所同意，公司公开发行人民币普通股（A股）3,930.00万股，每股面值1.00元，发 行价格20.67元/股，募集资金总额人民币812,331,000.00元，扣除保荐承销费用（不 含税）人民币79,529,935.57元，减除其他与本次发行权益性证券直接相关的发行 费用人民币（不含税） ...